Alpha Teknova (TKNO) Other Non-Current Assets (2020 - 2026)
Alpha Teknova (TKNO) reported Other Non-Current Assets of $1.2 million for Q1 2026, down 9.4% year-over-year from $1.3 million in Q1 2025, and down 7.0% quarter-over-quarter from $1.3 million in Q4 2025.
Alpha Teknova (TKNO) Other Non-Current Assets (2020 - 2026) Analysis & Trends
Alpha Teknova (TKNO) has 7 years of Other Non-Current Assets data on file, last reported at $1.2 million in Q1 2026.
- Other Non-Current Assets for Q1 2026 came in at $1.2 million, down 9.4% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.2 million (down 9.4% YoY), and the FY2025 annual result was $1.3 million, down 7.02% from the prior year.
- Other Non-Current Assets eased to $1.2 million in Q1 2026 per TKNO's latest filing, from $1.3 million in the prior quarter.
- Over five years, Other Non-Current Assets peaked at $2.3 million in Q4 2022 and troughed at $396000.0 in Q1 2022.
- A 5-year average of $1.5 million and a median of $1.4 million in 2024 frame the typical range for Other Non-Current Assets.
- The sharpest annual moves came in 2022 and 2024: Other Non-Current Assets soared 3955.17% in 2022, then fell 25.38% in 2024.
- A 5-year view of Other Non-Current Assets shows it stood at $2.3 million in 2022, then declined by 17.76% to $1.9 million in 2023, then slipped by 25.38% to $1.4 million in 2024, then slipped by 7.02% to $1.3 million in 2025, then decreased by 7.0% to $1.2 million in 2026.
- Business Quant data shows TKNO's Other Non-Current Assets at $1.2 million in Q1 2026, $1.3 million in Q4 2025, and $1.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 1.79 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 351.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 233.20 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 3.45 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 73.60 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 295.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 59.36 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 47.63 Mn |
| 10 | Alpha Teknova | 249.27 Mn | 231.49 Mn | 3.78 Mn | 1.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.20 Mn |
| Dec 31, 2025 | 1.29 Mn |
| Sep 30, 2025 | 1.32 Mn |
| Jun 30, 2025 | 1.35 Mn |
| Mar 31, 2025 | 1.32 Mn |
| Dec 31, 2024 | 1.38 Mn |
| Sep 30, 2024 | 1.52 Mn |
| Jun 30, 2024 | 1.65 Mn |
| Mar 31, 2024 | 1.74 Mn |
| Dec 31, 2023 | 1.85 Mn |
| Sep 30, 2023 | 1.95 Mn |
| Jun 30, 2023 | 2.03 Mn |
| Mar 31, 2023 | 2.15 Mn |
| Dec 31, 2022 | 2.25 Mn |
| Sep 30, 2022 | 1.18 Mn |
| Jun 30, 2022 | 769,000.00 |
| Mar 31, 2022 | 396,000.00 |
| Dec 31, 2021 | 180,000.00 |
| Sep 30, 2021 | 29,000.00 |
| Jun 30, 2021 | 31,000.00 |